IAA
GILD icon

Independent Advisor Alliance’s Gilead Sciences GILD Stock Holding History

Independent Advisor Alliance’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.84M Buy
38,289
+4,803
+14% +$633K 0.11% 132
2026
Q1 		$4.67M Buy
33,486
+454
+1% +$63.6K 0.05% 325
2025
Q4 		$4.05M Sell
33,032
-338
-1% -$41.1K 0.1% 166
2025
Q3 		$3.7M Buy
33,370
+350
+1% +$39.8K 0.1% 180
2025
Q2 		$3.66M Sell
33,020
-1,415
-4% -$151K 0.11% 170
2025
Q1 		$3.86M Buy
34,435
+2,307
+7% +$238K 0.13% 149
2024
Q4 		$2.97M Buy
32,128
+8,398
+35% +$756K 0.04% 403
2024
Q3 		$1.99M Buy
23,730
+270
+1% +$20.6K 0.07% 224
2024
Q2 		$1.61M Buy
23,460
+6,594
+39% +$440K 0.06% 253
2024
Q1 		$1.24M Buy
16,866
+1,513
+10% +$116K 0.04% 287
2023
Q4 		$1.24M Buy
15,353
+975
+7% +$75.9K 0.04% 274
2023
Q3 		$1.08M Buy
14,378
+7,794
+118% +$599K 0.05% 285
2023
Q2 		$507K Buy
6,584
+756
+13% +$60.3K 0.02% 424
2023
Q1 		$484K Buy
+5,828
New +$483K 0.02% 429
2022
Q4 		– Sell
-8,201
Closed -$506K – 504
2022
Q3 		$506K Buy
8,201
+868
+12% +$54.7K 0.03% 371
2022
Q2 		$453K Sell
7,333
-426
-5% -$26.4K 0.03% 390
2022
Q1 		$461K Buy
7,759
+357
+5% +$22.8K 0.02% 413
2021
Q4 		$537K Buy
7,402
+230
+3% +$15.8K 0.03% 380
2021
Q3 		$501K Sell
7,172
-436
-6% -$30.6K 0.03% 381
2021
Q2 		$524K Buy
7,608
+659
+9% +$44K 0.03% 383
2021
Q1 		$449K Sell
6,949
-309
-4% -$19.9K 0.03% 395
2020
Q4 		$423K Sell
7,258
-1,030
-12% -$62.2K 0.03% 374
2020
Q3 		$524K Sell
8,288
-32,560
-80% -$2.26M 0.04% 286
2020
Q2 		$932K Buy
40,848
+23,756
+139% +$1.82M 0.1% 167
2020
Q1 		$1.28M Buy
17,092
+8,822
+107% +$610K 0.19% 97
2019
Q4 		$537K Sell
8,270
-631
-7% -$41.1K 0.02% 512
2019
Q3 		$564K Buy
8,901
+475
+6% +$31.1K 0.07% 238
2019
Q2 		$569K Buy
8,426
+219
+3% +$14.4K 0.08% 209
2019
Q1 		$534K Sell
8,207
-632
-7% -$42K 0.08% 224
2018
Q4 		$553K Buy
8,839
+851
+11% +$59.5K 0.1% 182
2018
Q3 		$526K Buy
7,988
+765
+11% +$57.8K 0.09% 185
2018
Q2 		$440K Sell
7,223
-350
-5% -$24.7K 0.09% 200
2018
Q1 		$555K Sell
7,573
-123
-2% -$9.78K 0.12% 181
2017
Q4 		$573K Buy
7,696
+162
+2% +$12.3K 0.13% 168
2017
Q3 		$618K Buy
7,534
+337
+5% +$25.8K 0.17% 139
2017
Q2 		$499K Sell
7,197
-3,679
-34% -$245K 0.16% 147
2017
Q1 		$723K Sell
10,876
-12,150
-53% -$854K 0.11% 197
2016
Q4 		$1.64M Buy
+23,026
New +$1.71M 0.7% 42

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Independent Advisor Alliance's GILD Position: Q2 2026 in Review

Independent Advisor Alliance increased its Gilead Sciences (GILD) stake by 14% in Q2 2026, buying an estimated $633K and bringing the position to 38,289 shares worth $4.84M. The position accounts for 0.11% of the portfolio, ranked #132.

Independent Advisor Alliance first reported a position in GILD in Q4 2016 and has held it in 38 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Independent Advisor Alliance held 38,289 shares of Gilead Sciences worth $4.84M as of Q2 2026.
  • Independent Advisor Alliance bought 4,803 Gilead Sciences shares in Q2 2026, an estimated $633K.
  • Gilead Sciences made up 0.11% of Independent Advisor Alliance's portfolio in Q2 2026, its #132 holding.
  • Independent Advisor Alliance first reported a position in Gilead Sciences in Q4 2016 and has held it in 38 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Independent Advisor Alliance's 13F filing for Q2 2026, filed 12 Aug 2026.